PlainRecalls
FDA Drug Moderate Class II Completed

OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator contained within carton, Rx only, Allergan Inc Irvine, CA 92612, NDC 0023-3348-07

Reported: January 16, 2019 Initiated: December 20, 2018 #D-0387-2019

Product Description

OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator contained within carton, Rx only, Allergan Inc Irvine, CA 92612, NDC 0023-3348-07

Reason for Recall

GMP Deviations: A silicone particulate was noted in Ozurdex.

Details

Recalling Firm
Allergan, PLC.
Units Affected
133,716 Cartons
Distribution
Product was distributed to various accounts throughout the United States including VA and Government Accounts
Location
Madison, NJ

Frequently Asked Questions

What product was recalled?
OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator contained within carton, Rx only, Allergan Inc Irvine, CA 92612, NDC 0023-3348-07. Recalled by Allergan, PLC.. Units affected: 133,716 Cartons.
Why was this product recalled?
GMP Deviations: A silicone particulate was noted in Ozurdex.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 16, 2019. Severity: Moderate. Recall number: D-0387-2019.